Location History:
- Penzburg, DE (1995 - 1997)
- Penzberg, DE (1994 - 2013)
Company Filing History:
10 out of 1,164 
1 out of 1,650 
1 out of 480 
Years Active: 1994-2013
Title: **Rudolf Seibl: Innovator in Oligonucleotide Synthesis and PCR Technology**
Introduction
Rudolf Seibl, based in Penzberg, Germany, is a notable inventor in the field of molecular biology, particularly known for his contributions to oligonucleotide synthesis and polymerase chain reaction (PCR) technologies. With a total of 13 patents to his name, his innovations have significantly advanced laboratory procedures and diagnostics, enhancing the efficiency and accuracy of nucleic acid analysis.
Latest Patents
Two of Rudolf Seibl's latest patents include an integrated instrument performing synthesis and amplification, and a method for sensitive detection of nucleic acids. The integrated instrument, which is composed of two independent modules, serves dual functions: it facilitates the chemical de novo synthesis of oligonucleotides and performs real-time analytical PCR (qPCR). This allows users to analyze nucleic samples seamlessly, without the need for prior external synthesis of amplification primers.
Additionally, his method for the sensitive detection of nucleic acids involves a detailed process where target nucleic acids can be hybridized and detected through a series of strategic steps involving probe nucleic acids. The innovations embodied in these patents underscore Seibl’s commitment to improving the accuracy of nucleic acid detection and analysis.
Career Highlights
Throughout his career, Rudolf Seibl has made significant contributions while working at renowned companies such as Boehringer Mannheim GmbH and Roche Diagnostics Operations, Inc. His experiences in these organizations have provided him with a rich environment for developing cutting-edge technologies that address prevalent challenges in molecular diagnostics and research.
Collaborations
Rudolf Seibl has collaborated with esteemed professionals including Christoph Kessler and Viola Rosemeyer. These collaborations have resulted in innovative projects that fostered advancements in the fields of oligonucleotide synthesis and PCR technology, further establishing his reputation as a leading inventor.
Conclusion
Rudolf Seibl's impressive portfolio of patents and contributions to molecular biology demonstrate his influence in the field. His latest innovations not only streamline the processes of oligonucleotide synthesis and detection of nucleic acids but also pave the way for future advancements in diagnostics and laboratory techniques. With a career that reflects a passion for innovation, Seibl continues to inspire both current and future generations of scientists and researchers.